Caveolin-1 exists and may function in cardiomyocytes

被引:18
作者
Cho, Woo Jung [1 ]
Chow, Ava K. [2 ]
Schulz, Richard [1 ,2 ]
Daniel, Edwin E. [1 ]
机构
[1] Univ Alberta, Dept Pharmacol, Edmonton, AB T6G 2H7, Canada
[2] Univ Alberta, Dept Pediat, Edmonton, AB T6G 2H7, Canada
关键词
MMP-2; localization of caveolin-1; immunohistochemistry; caveolin-2; endothelial cells; cardiomyocytes; MATRIX METALLOPROTEINASE-2; KINASE; HEART; MICE;
D O I
10.1139/Y09-114
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Whether ventricular cardiac myocytes of mouse contain caveolin-1 is disputed. It has been claimed to he exclusively in nearby endothelial cell profiles. Recently, matrix metalloproteinase-2 (MMP-2) was reported to be present in mouse ventricular cardiac myocytes, colocalized with caveolin-1, and caveolin-1 knockout was found to cause the loss of MMP-2 from mouse ventricular cardiac myocytes and affect their functioning. To resolve this dispute, We labeled cardiac myocytes with caveolin-1 and endothelial cells with caveolin-2. Caveolin-2 is agreed to be present exclusively in endothelial cells. The results showed that mouse ventricular myocytes were labeled with caveolin-1 antibodies independently of any caveolin-2 labeling, and endothelial cells were labeled with both caveolin-1 and caveolin-2 antibodies. This confirms that caveolin-1 is present in mouse ventricular cardiac myocytes its well its endothelial cells. Previous evidence confirms that loss of caveolin-1 affects the function of mouse ventricular cardiac myocytes and Suggests that MMP-2 may be involved.
引用
收藏
页码:73 / 76
页数:4
相关论文
共 7 条
[1]   Matrix metalloproteinase-2, caveolins, focal adhesion kinase and c-Kit in cells of the mouse myocardium [J].
Cho, Woo Jung ;
Chow, Ava K. ;
Schulz, Richard ;
Daniel, Edwin E. .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2007, 11 (05) :1069-1086
[2]   Caveolin-1 inhibits matrix metalloproteinase-2 activity in the heart [J].
Chow, A. K. ;
Cena, J. ;
El-Yazbi, A. F. ;
Crawford, B. D. ;
Holt, A. ;
Cho, W. J. ;
Daniel, E. E. ;
Schulz, R. .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2007, 42 (04) :896-901
[3]   Caveolin-1 null mice develop cardiac hypertrophy with hyperactivation of p42/44 MAP kinase in cardiac fibroblasts [J].
Cohen, AW ;
Park, DS ;
Woodman, SE ;
Williams, TM ;
Chandra, M ;
Shirani, J ;
De Souza, AP ;
Kitsis, RN ;
Russell, RG ;
Weiss, LM ;
Tang, BY ;
Jelicks, LA ;
Factor, SM ;
Shtutin, V ;
Tanowitz, HB ;
Lisanti, MP .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2003, 284 (02) :C457-C474
[4]   Freeze-fracture replica immunolabelling reveals caveolin-1 in the human cardiomyocyte plasma membrane [J].
Robenek, Horst ;
Weissen-Plenz, Gabriele ;
Severs, Nicholas J. .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2008, 12 (6A) :2519-2521
[5]   Caveolin-1 and caveolin-3 form heterooligomeric complexes in atrial cardiac myocytes that are required for doxorubicin-induced apoptosis [J].
Volonte, Daniela ;
McTiernan, Charles F. ;
Drab, Marek ;
Kasper, Michael ;
Galbiati, Ferruccio .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2008, 294 (01) :H392-H401
[6]   Disruption of caveolin-1 leads to enhanced nitrosative stress and severe systolic and diastolic heart failure [J].
Wunderlich, C ;
Schober, K ;
Lange, SA ;
Drab, M ;
Braun-Dullaeus, RC ;
Kasper, M ;
Schwencke, C ;
Schmeisser, A ;
Strasser, RH .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 340 (02) :702-708
[7]   Defects in caveolin-1 cause dilated cardiomyopathy and pulmonary hypertension in knockout mice [J].
Zhao, YY ;
Liu, Y ;
Stan, RV ;
Fan, L ;
Gu, YS ;
Dalton, N ;
Chu, PH ;
Peterson, K ;
Ross, J ;
Chien, KR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (17) :11375-11380